Pulling SEC filings + quote and writing the call…

Bioventus Inc.
Next earnings Aug 4, 2026 · consensus $0.22 EPS, $157M rev
Last earnings +2.2% on 2026-05-06
Revenue declined -0.9% YoY.
Bioventus Inc. shows $568M in FY2025 revenue (-0.9% YoY), a 4.0% net margin, and 12.3% ROE.
Sources: SEC EDGAR (CIK 0001665988, latest 10-Q filed 2026-05-06) · as of 6/26/2026, 7:22:24 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $431M | $512M | $512M | $573M | $568M |
| Gross profit | $303M | $331M | $328M | $388M | $388M |
| Operating income | $12.1M | -$167M | -$81.7M | -$15.2M | $54.0M |
| Net income | $19.4M | -$159M | -$156M | -$36.1M | $22.7M |
| Diluted EPS | -$0.15 | -$2.59 | -$2.49 | -$0.56 | $0.33 |
| Net margin | 4.5% | -31.0% | -30.5% | -6.3% | 4.0% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
| 2026-06-02 | Bartholdson John A. Director | Exercise | 32.3K | |
| 2026-06-02 | SUTTER MARTIN P Director | Exercise | 32.3K | |
| 2026-06-02 | STALNECKER SUSAN M Director | Exercise | 32.3K | |
| 2026-06-02 | NOHRA GUY P Director | Exercise | 32.3K | |
| 2026-06-02 | NEELS GUIDO J Director | Exercise | 32.3K | |
| 2026-06-02 | McMurry-Heath Michelle Director | Exercise | 32.3K | |
| 2026-06-02 | Ladone Mary Kay Director | Exercise | 32.3K | |
| 2026-06-02 | HAWKINS WILLIAM A Director | Exercise | 39.8K |
1047 tracked peers · median
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.